| BIOMARIN PHARMACEUTICAL INC |
Director |
Common Stock |
13,555 |
$853,693 |
$62.98 |
20 May 2025 |
Direct |
| Enovis CORP |
Director |
Common stock, par value $0.001 |
14,855 |
$518,588 |
$34.91 |
21 May 2025 |
Direct |
| Option Care Health, Inc. |
Director |
Common Stock |
12,090 |
$371,042 |
$30.69 |
14 May 2025 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Common Stock |
0 |
|
$155.73 |
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Performance-Based Restricted Stock Units (11/06/2019) |
0 |
|
|
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Performance-Based Restricted Stock Units (11/11/2020) |
0 |
|
|
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Restricted Stock Units (11/06/2019) |
0 |
|
|
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Restricted Stock Units (11/10/2021) |
0 |
|
|
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Restricted Stock Units (11/11/2020) |
0 |
|
|
13 Dec 2021 |
Direct |
| Hill-Rom Holdings, Inc. |
SVP, Chief Financial Officer |
Employee Stock Option (Right to Buy) |
0 |
|
$61.86 |
13 Dec 2021 |
Direct |
| Syneos Health, Inc. |
Director |
Class A Common Stock |
0 |
|
$43.00 |
28 Sep 2023 |
Direct |
| Turning Point Therapeutics, Inc. |
Director |
Stock Option (right to buy) |
0 |
|
|
17 Aug 2022 |
Direct |